Oriel Therapeutics, a developer of inhaled drug delivery technology, has received its third U.S. patent related to dry power inhalers.
The patent applies to dry power dose filing systems and methods.
Oriel’s technology was licensed from the University of North Carolina at Chapel Hill.
Oriel: www.orieltherapeutics.com
